CL

Business profile & competitive position

Colgate-Palmolive Company is classified in the Consumer Defensive sector, specifically the Household & Personal Products industry. It operates through two main segments: Oral, Personal and Home Care (toothpaste, toothbrushes, soaps, deodorants, skin health products, cleaners, fabric conditioners and similar items) and Hill's Pet Nutrition (specialty dog and cat foods). The company markets its products in more than 200 countries and territories through retailers, wholesalers, eCommerce retailers, veterinarians and certain direct-to-consumer channels.

Reading the financials alongside that profile gives a specific picture of the business. The 9.7% net margin is solid but not extraordinary, which is typical for a large consumer staples manufacturer that balances brand pricing power against advertising, promotion and input costs. The reported return on equity of 631.1% is exceptionally high; with a single-digit net margin, that scale of ROE is usually driven by leverage and a small equity base rather than by operating margin alone. The beta of 0.33 confirms the stock has been far less volatile than the broader market, consistent with the recurring, non-discretionary demand that toothpaste, soap and pet food tend to generate.

Financial posture

Colgate-Palmolive carries a market capitalization of $71.9 billion and trades at a trailing P/E of 35.3. That valuation is meaningfully above the net margin of 9.7% would imply on a pure profitability basis, which suggests investors are pricing in durable cash flows, global brand stability and low earnings volatility rather than high growth. The 631.1% ROE amplifies the point that embedded leverage is a large part of the equity-return story. The beta of 0.33 underlines the defensive posture: the stock historically moves only about a third as much as the overall market. No long-term debt figure was supplied in the data, so any leverage discussion here is framed around the ROE signal rather than a precise debt load.

Strategic priorities & outlook

The company’s most recent 10-K filing outlines a strategy centered on four operational priorities: driving organic sales growth and delivering consistent, compounded earnings-per-share growth; achieving operational efficiencies while growing free cash flow and using the balance sheet efficiently; leveraging global brand reach, science-based innovation, an agile supply chain and best-in-class omni-channel demand generation; and building capabilities in data, analytics and artificial intelligence while evolving what it calls a high-impact, inclusive culture.

Segment concentration is worth noting. In 2025, Oral Care accounted for 44% of worldwide net sales, Personal Care for 17%, Home Care for 16% and Pet Nutrition for 23%. Walmart and its affiliates represented roughly 11% of 2025 net sales, with no other customer exceeding 10%. As of December 31, 2025, the company employed about 33,600 people across more than 100 countries, with over 84% located outside the United States. That footprint is central to the growth story, but it also means currency, cross-border logistics and local competition are built into the strategic plan.

Macro & geopolitical exposure

As a Household & Personal Products business, Colgate-Palmolive sits in a sector exposed to several macro forces. Because more than 84% of its workforce is outside the United States and it sells in over 200 countries, foreign-currency translation is a persistent factor in reported revenue and earnings. Commodity-like inputs — including surfactants, oils, packaging resins, agricultural commodities for pet food and energy for manufacturing and shipping — directly affect cost of goods sold. The industry is also sensitive to freight and logistics disruptions, trade policy, tariffs and regulatory scrutiny around product claims, packaging sustainability and ingredient standards.

On the demand side, consumer staples are generally recession-resistant, but they are not immune to volume pressure or private-label substitution when household budgets tighten. Retail concentration adds another layer of exposure: Walmart and its affiliates accounted for about 11% of net sales, meaning a shift in shelf space, pricing terms or inventory policy at a major retailer can ripple through results. Pet Nutrition, meanwhile, adds exposure to the veterinary and premium pet-food channel, which can be influenced by animal-health trends and ingredient-cost cycles.

Recent developments

Recent headlines around the stock have been limited and largely routine. On August 27, 2026, Colgate-Palmolive webcast a fireside chat at the Barclays 2026 Global Consumer Staples Conference, according to businesswire.com. On the same day, defenseworld.net reported that Algert Global LLC sold 9,986 shares. Earlier that week, Allstate Corp sold 29,541 shares on August 24, 2026, and Allworth Financial LP cut its holdings on August 22, 2026, both also per defenseworld.net. These are small institutional position changes and do not, on their own, indicate a broader shift in company fundamentals or analyst sentiment. As of the current snapshot, the stock was priced at $89.83 with an RSI of 44.2 and a 50-day EMA of $91.24 — sitting modestly below that short-term average heading into the next quarterly report.

Earnings behavior & post-earnings drift

Colgate-Palmolive has an exceptionally clean earnings record over the last eight reported quarters, posting beats in all eight for a 100% beat rate, with an average earnings surprise of 3.3%. The average five-day price move following those reports is 2.32% to the upside, and the drift direction is classified as "up."

The four most recent quarters reinforce that pattern while showing some near-term volatility. On July 31, 2026, the company reported EPS of $0.99 against the estimate of $0.947, a 4.5% surprise; the stock fell 1.56% the next day but rose 2.16% over the following five sessions. On May 1, 2026, actual EPS was $0.97 versus $0.943 estimated, a 2.9% surprise; the stock dropped 2.17% the next day and edged up 0.33% over five days. On January 30, 2026, EPS came in at $0.95 versus $0.912 estimated, a 4.2% surprise, with a 1.77% next-day gain and a 4.56% five-day drift. On October 31, 2025, the company reported $0.91 versus $0.889 estimated, a 2.4% surprise; the stock fell 2.69% the next day but recovered 2.22% over the next five trading days. The next scheduled report is October 30, 2026, before the market open, with a consensus EPS estimate of $0.92.

For a deeper dive into how institutional analysts are currently weighing these numbers, valuation and upcoming catalysts, review the full institutional verdict on Colgate-Palmolive.